Journal of the Endocrine Society Editors and Editorial Board
Editor-in-Chief
Zeynep Madak-Erdogan, PhD
University of Illinois at Urbana-Champaign
Urbana, Illinois, USA
Dr. Madak-Erdogan is Sylvia D. Stroup Scholar of Nutrition and Cancer, Associate Dean of Graduate College, and Cancer Center Program Leader at the University of Illinois, Urbana-Champaign (UIUC). She received her PhD and undertook postdoctoral studies on mechanisms of nuclear receptor action at UIUC. She has been a faculty member in the Department of Food Science and Human Nutrition since 2014, and the Department of Biomedical and Translational Sciences at the Carle-Illinois College of Medicine since 2020. Her lab uses advanced computational analysis of ‘omics data from patient samples and in vivo and in vitro cancer models to understand how hormones and the environment impact disparities associated with metabolic health and cancer outcomes. She has built a strong and diverse laboratory and mentors high school students, undergraduates, graduate students, and postdoctoral associates. Madak-Erdogan teaches courses in Cancer Metabolism, Basic Toxicology, Diet, Nutrition and Cancer, and Women’s Health. She has received several awards, including a Postdoctoral Fellowship from a National Institute of Environmental Health Sciences Training Grant in Endocrine Developmental and Reproductive Toxicology, a fellowship from the National Center for Supercomputing Applications, the Women in Endocrinology Young Investigator Award from the Endocrine Society, the Mary Swartz Rose Young Investigator Award, the Bio-Serv Experimental Nutrition Award from the American Society for Nutrition, and she was named a Future Research Leader and a Health Disparities Research Institute Scholar by NIH. She was selected as a National Academy of Medicine Emerging Leader in 2023.
Deputy Editor
Stephen R. Hammes, MD, PhD
University of Rochester School of Medicine and Dentistry
Rochester, New York, USA
Dr. Hammes is the Louis S. Wolk Distinguished Professor of Medicine at the University of Rochester. He is also the Chief of the Division of Endocrinology, Diabetes, and Metabolism, as well as the Vice Chair for Research and Academic Affairs in the Department of Medicine. Dr. Hammes has served as Editor-in-Chief of the Endocrine Society journals Molecular Endocrinology and Endocrinology. He is a member of the American Society for Clinical Investigation. Dr. Hammes’ research interests include steroidogenesis and steroid signaling, with a focus on extranuclear, or nongenomic, steroid effects. He studies these processes in the setting of female reproduction as well as in hormone-sensitive cancers such as prostate cancer and in lymphangioleiomyomatosis (LAM).
Associate Editors
Madson Q. Almeida, MD, PhD
University of São Paulo
São Paulo, Brazil
Dr. Almeida is Professor of Endocrinology and Tenured Investigator at the Adrenal Unit, Division of Endocrinology, Clinics Hospital & Division of Endocrine Oncology, São Paulo State Cancer Institute, University of São Paulo Medical School. He did a postdoctoral fellowship at National Institutes of Health after earning his PhD at the University of São Paulo. He has served on the editorial board of The Journal of Clinical Endocrinology & Metabolism and has recently joined the editorial board of the JCEM Case Reports. His research interests include the molecular basis and clinical management of endocrine hypertension. His projects apply basic science knowledge to clinical diagnosis, pathophysiology, and treatment of primary aldosteronism and pheochromocytomas and paragangliomas.
Robert D. Blank, MD, PhD
Medical College of Wisconsin
Milwaukee, Wisconsin, USA
and
Garvan Institute of Medical Research
Sydney, Australia
Robert Blank is Professor Emeritus of Medicine at the Medical College of Wisconsin and a Visiting Scientist at the Garvan Institute of Medical Research in Sydney, Australia. He is a past president of the International Society of Clinical Densitometry and is active in various international efforts to improve the care of low-trauma fracture patients. He holds multiple other associate editor and editorial board positions. He has a long-standing interest in the genetic determination of bone size, structure, and biomechanical performance. Current lab work addresses paracrine signaling in cortical bone and current clinical work addresses the contribution of mobility impairment to health risks.
Kristien Boelaert, MD, PhD, FRCP
University of Birmingham
Birmingham, United Kingdom
Kristien Boelaert is a Professor of Endocrinology at the University of Birmingham. Her clinical research interests include the management of thyroid dysfunction, nodules, and cancer, as well as endocrine disorders in pregnancy. Her laboratory research focuses on the pathogenesis of thyroid cancer. She led the NICE (National Institute for Health and Care Excellence) Guidelines on Thyroid Diseases and UK Guidance on Management of Thyroid Cancer. She is a member of the Working Groups on Thyroid Diseases in Pregnancy for the American Thyroid Association and the Royal College of Obstetricians and Gynaecologists. Dr. Boelaert’s research attracts funding from major grant-awarding bodies and she is a regular speaker at national and international conferences. She serves on the editorial boards of The Lancet Diabetes & Endocrinology and Clinical Endocrinology. She is a member of the Society for Endocrinology Council and Clinical Committee, the American Thyroid Association Awards Committee, the Endocrine Society Annual Steering Meeting Committee, and the Royal College of Physicians Specialist Certificate Examination Board.
M. Furkan Burak, MD
Brigham and Women’s Hospital / Harvard Medical School
Boston, Massachusetts, USA
Dr. Burak is an endocrinologist and faculty member who leads the translational immunometabolism research group at Brigham and Women’s Hospital / Harvard Medical School. He also serves as a basic science researcher at the Harvard Chan School of Public Health, Department of Molecular Metabolism. His research mainly focuses on the role of adipose tissue-derived molecules in obesity and development of new therapeutic strategies in obesity related immunometabolic diseases such as diabetes, fatty liver disease, and asthma. He is triple board certified in Internal Medicine and Endocrinology, Diabetes and Metabolism, and Obesity Medicine. His clinical practice focuses on obesity, diabetes, and immunometabolism. Additionally, he was appointed to MassHealth Drug Utilization Review Board as the sole endocrinologist by the Governor of Massachusetts. He has contributed to the obesity and immunometabolism field with high impact publications, patents, book chapters, and has received many prestigious awards including Early Investigator Award of the Endocrine Society, United Nations Top Outstanding Young Persons of the World medical innovation and scientific development award, and the Charles A. King-Bank of America Trust Fellowship.
Dana Dabelea, MD, PhD
University of Colorado Anschutz Medical Campus
Aurora, Colorado, USA
Dr. Dabelea is the Conrad M. Riley Endowed Professor of Epidemiology (Colorado School of Public Health) and Pediatrics (School of Medicine), the Director of the Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, and a Distinguished Professor at the University of Colorado Anschutz Medical Campus. Dr. Dabelea is an internationally recognized expert in pediatric obesity, diabetes, and lifecourse epidemiology, and a recipient of the prestigious Kelly West award in Diabetes Epidemiology from the American Diabetes Association. Her interests focus on the understanding of the complex and multifactorial etiology of diabetes, both type 1 and type 2, with a goal of preventing its occurrence, and reducing or preventing its complications throughout the lifecourse. As the Director of the LEAD Center, she oversees large, longitudinal, cohort studies spanning the entire lifecourse, from pregnancy through old age.
Quan-Yang Duh, MD
University of California, San Francisco
San Francisco, California, USA
Dr. Quan-Yang Duh is Professor of Surgery and Chief of Section of Endocrine Surgery at the University of California, San Francisco (UCSF) and Attending Surgeon at the Veterans Affairs Medical Center, San Francisco. Dr. Duh obtained his MD from UCSF. He specializes in surgery for tumors of the thyroid, parathyroid, and adrenal glands, as well as endocrine pancreas and gastrointestinal tumors. Dr. Duh is Past President of the American Association of Endocrine Surgeons and was a recipient of its Oliver Cope Meritorious Achievement Award. He was the American Thyroid Association (ATA) Paul Starr Award Lecturer in 2017. He has published more than 400 papers and co-edited three textbooks on endocrine surgery. Dr. Duh is on the editorial board of Thyroid, JAMA-Surgery, Video Endocrinology and other publications.
Marina Olga Fernandez, PhD
Instituto de Biología y Medicina Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas (IByME-CONICET)
Buenos Aires, Argentina
Dr Fernandez is an Associate Researcher of CONICET at the Instituto de Biología y Medicina Experimental in Buenos Aires, Argentina. Her interests involve understanding how environmental stimuli, such as components of the diet and contaminants, affect the endocrine system. She is presently studying the effects of endocrine-disrupting chemicals on the physiology of the hypothalamic-pituitary axis. She is author or co-author of several papers and a book chapter, and serves as a peer reviewer for academic journals. She is also peer reviewer of grants, promotions, and entries to the Scientific Researcher Career Program of CONICET and FONCyT grants in her home country.
Bruno Ferraz-de-Souza, MD, PhD
University of Notre Dame Australia
Fremantle, Australia
Dr. Ferraz-de-Souza is an Associate Professor and Domain Chair for Basic and Clinical Sciences at the University of Notre Dame Australia School of Medicine in Fremantle, Australia, and an Honorary Principal Investigator and Postgraduate Supervisor in Endocrinology at the University of Sao Paulo School of Medicine, in Sao Paulo, Brazil. Clinically trained in Endocrinology at USP, he received his PhD in Endocrinology from University College London (UCL), London, UK, in 2011. Dr Ferraz-de-Souza is an Associate Editor for Archives of Endocrinology and Metabolism, the official journal of the Brazilian Society of Endocrinology and Metabolism (SBEM), and a Senior Editor for Endocrine Connections. He has been chair of the Endocrine Society Publication Core Committee since 2022, and was previously chair of the Committee on Diversity and Inclusion. His research interests include the molecular basis and clinical management of metabolic bone disorders and the molecular diagnosis of rare and common endocrinopathies.
Ana Claudia Latronico, MD, PhD
University of São Paulo
São Paulo, Brazil
Dr. Latronico is a full professor of endocrinology at São Paulo Medical School, University of São Paulo, and serves as director of the Division of Endocrinology and Metabolism at Hospital das Clinicas, São Paulo, Brazil. She earned her PhD at the University of São Paulo after research training at National Institutes of Health. She has served on the editorial boards of The Journal of Clinical Endocrinology & Metabolism and Endocrine Reviews. Her clinical and research activities focus on clinical and molecular diagnosis of human pubertal disorders, as well as identification of biomarkers and prognostic factors of human adrenocortical tumors. Dr. Latronico has made important observations on the genetic causes of central pubertal disorders, such as central precocious puberty and congenital hypogonadotropic hypogonadism.
Zhenqi Liu, MD
University of Virginia
Charlottesville, Virginia, USA
Dr. Liu is the James M. Moss Professor of Diabetes and Professor of Medicine at the University of Virginia School of Medicine. His research involves translational studies on insulin action and insulin resistance, endothelial function and vascular biology, and energy metabolism. Dr. Liu has previously served as Chief of the Division of Endocrinology and Metabolism at the University of Virginia and an associate editor for Reviews in Endocrine and Metabolic Disorders, and on multiple grant review panels and study sections and the editorial boards of The Journal of Clinical Endocrinology & Metabolism and The American Journal of Physiology – Endocrinology and Metabolism. He co-chaired the Endocrine Society International Scholars Program Task Force.
Rebecca B. Riggins, PhD
Georgetown University Medical Center
Washington, DC, USA
Dr. Riggins is an Associate Professor in the Department of Oncology at Georgetown University in the Lombardi Comprehensive Cancer Center (LCCC). Her laboratory studies the role of orphan and ligand-regulated nuclear receptors – notably the estrogen and estrogen-related receptors – in multiple malignancies, with the goal of translating knowledge of the cellular and molecular functions of these proteins into actionable therapeutic approaches. She has a special interest in the biology of invasive lobular and HER2+/ER+ breast cancer, and is a member of the scientific advisory board for the Lobular Breast Cancer Alliance. Dr. Riggins is also LCCC’s Associate Director of Education and Training.
Roberto Salvatori, MD
Johns Hopkins University
Baltimore, Maryland, USA
Dr. Roberto Salvatori graduated summa cum laude with from Catholic University School of Medicine in his native Rome, Italy. After endocrinology training in the same institution, he trained in Internal Medicine at the Montefiore Medical Center of Albert Einstein University in the Bronx, NY, and completed fellowships in Endocrinology and Metabolism at Cornell University in New York and at the Johns Hopkins University School of Medicine. He joined the Johns Hopkins faculty in 1998 and is currently a Professor of Medicine and Neurosurgery. One of the founders of the Johns Hopkins Pituitary Center, Dr. Salvatori focuses his clinical practice and research on the diagnosis and treatment of pituitary tumors and pituitary dysfunction, with a particular interest in the genetic causes of growth hormone (GH) deficiency, in GH excess (acromegaly) on cortisol excess (Cushing) and deficiency (adrenal insufficiency), and on the predictors of response to medical therapy prolactinomas. He is an Associate Editor for the journal Pituitary and is one the content writers of the Endocrine Society Endocrinology Self Assessment Program (ESAP)
Lindsey S. Treviño, PhD
City of Hope National Medical Center
Duarte, California, USA
Dr.Treviño is an Assistant Professor in the Division of Health Equities and Department of Population Sciences at City of Hope National Medical Center. Current research projects in her laboratory are focused on understanding the link between epigenomic reprogramming by endocrine disrupting chemicals and development/progression of fatty liver disease and breast cancer – diseases with known disparities. Dr. Treviño has been selected as a FLARE (Future Leaders Advancing Research in Endocrinology) Fellow and a Keystone Symposia Fellow. She previously served on the Committee on Diversity and Inclusion, on the Governance Task Force, on the Research Affairs Core Committee, and on the Board of Directors of the Endocrine Society.
Selma Feldman Witchel, MD
UPMC Children’s Hospital of Pittsburgh
Pittsburgh, Pennsylvania, USA
Dr. Witchel is a Professor of Pediatrics at the University of Pittsburgh in Pittsburgh, Pennsylvania. She is the Director of the Pediatric Endocrinology Fellowship Program at the UPMC Children’s Hospital of Pittsburgh. She is a Past President of the Androgen Excess-Polycystic Ovary Syndrome Society. She has served as an editorial board member of The Journal of Clinical Endocrinology & Metabolism, the Journal of Pediatric and Adolescent Gynecology, and Journal of the Endocrine Society. Dr. Witchel is currently serving on the Editorial Board of Sexual Development and is an associate editor of Steroids. Her clinical and research interests include disorders of androgen excess, disorders of puberty, glucocorticoid actions, and differences in sex development.
Disclosure Information for the Editor-in-Chief, Deputy Editor, and Associate Editors
Editorial Board
Adegbenga Bolanle Ademolu, MBBS
Lagos State University Teaching Hospital
Lagos, Nigeria
Sonir R.R. Antonini, MD, PhD
University of São Paulo
São Paulo, Brazil
Decio Armanini, MD
Università degli Studi di Padova
Padua, Italy
Leon A. Bach, MBBS, PhD, FRACP
Alfred Hospital
Melbourne, Australia
Traci Bekelman, PhD, MPH
Colorado School of Public Health
Aurora, Colorado, USA
Jerzy Bełtowski, MD, PhD
Medical University of Lublin
Lublin, Poland
Traci N. Bethea, PhD, MPA
Georgetown Lombardi Comprehensive Cancer Center
Washington, DC, USA
Vinicius Nahime Brito, MD, PhD
University of São Paulo
São Paulo, Brazil
Irene Campi, MD, PhD
IRCCS Istituto Auxologico Italiano
Milan, Italy
Rubén Cardozo, PhD
Ministerio de Salud Publica
Salta, Argentina
Paulo F. Collett-Solberg, MD, PhD
Universidade do Estado do Rio de Janeiro
Rio de Janeiro, Brazil
Margaret de Castro, MD, PhD
Ribeirao Preto Medical School - University of São Paulo
Ribeirao Preto, São Paulo, Brazil
Beverly E. Diamond, PhD
Columbia University (Ret)
Santa Fe, New Mexico, USA
Laura E. Dichtel, MD, MHS
Massachusetts General Hospital
Boston, Massachusetts, USA
Rivka Dresner-Pollak, MD
Hadassah Medical Organization - Hebrew University of Jerusalem
Jerusalem, Israel
Pamela U. Freda, MD
Columbia University
New York, New York, USA
Daniel A. Gorelick, PhD
Baylor College of Medicine
Houston, Texas, USA
Caroline M. Gorvin, DPhil
University of Birmingham
Birmingham, United Kingdom
Sasha Howard, MD, PhD
Queen Mary, University of London
London, United Kingdom
Najmul Islam, MD
Aga Khan University
Karachi, Pakistan
Bernard Khoo, MBBChir, PhD, FRCP
University College London
London, United Kingdom
Christian A. Koch, MD, PhD
The University of Tennessee Health Science Center
Memphis, Tennessee, USA
and
The University of Florida
Jacksonville, Florida, USA
Nils W. Lambrecht, MD, PhD, FCAP
American University of Health Sciences
Signal Hill, California, USA
and
Long Beach VA Hospital
Long Beach, California, USA
Xia Li, PhD
The Second Xiangya Hospital of Central South University
Changsha, China
Moisés Mercado, MD, FRCP(C)
Hospital de Especialidades Centro Medico Nacional Siglo XXI
Universidad Nacional Autónoma de México
Mexico City, Mexico
Madalina Musat, MD, PhD
Carol Davila University of Medicine and Pharmacy
Bucharest, Romania
Jerome Nwachukwu, PhD
Wertheim UF Scripps Institute
Jupiter, Florida, USA
Melissa O. Premaor, PhD
Universidade Federal de Minas Gerais
Belo Horizonte, Brazil
Joseph L. Shaker, MD
Medical College of Wisconsin
Milwaukee, Wisconsin, USA
Yutaka Takahashi, MD, PhD
Nara Medical University
Nara, Japan
Arthi Thirumalai, MD
University of Washington School of Medicine
Seattle, Washington, USA
Alfredo Ulloa-Aguirre, MD
National University of Mexico (UNAM)-INCMNSZ
Mexico City, Mexico
Varsha G. Vimalananda, MD, MPH
Boston University School of Medicine
Boston, Massachusetts, USA
Yi Zheng, MD, PhD
Army Medical University
Chongqing, China
Endocrine Society Staff
Richard T. O’Grady, PhD
Publisher
Timothy M. Beardsley, DPhil
Executive Editor
